Table 5. Mean (standard deviation) haematological parameters at screening (the last wash-out cycle) and post-treatment (end of treatment) of the 76 women.
| Biochemical | Four-Agents-Decoction | Placebo | ||
| Screening (n = 38) | Post-treatment (n = 38) | Screening (n = 38) | Post-treatment (n = 38) | |
| CA 125, U/mL | 17.9 (7.42) | 17.0 (9.85) | 17.9 (6.63) | 16.9 (9.08) |
| AST, IU/L | 18.6 (4.06) | 18.3 (3.31) | 18.1 (3.76) | 19.2 (4.62) |
| ALT, IU/L | 13.2 (5.72) | 13.7 (4.78) | 12.3 (5.75) | 12.4 (4.52) |
| Uric acid, mg/dL | 4.40 (1.32) | 4.17 (1.06) | 4.40 (1.15) | 4.28 (0.97) |
| Urea nitrogen, mg/dL | 10.5 (2.29) | 10.9 (2.85) | 11.2 (2.31) | 11.2 (2.87) |
| Creatinine, mg/dL | 0.79 (0.11) | 0.77 (0.08) | 0.79 (0.09) | 0.80 (0.08) |
| Lead, µg/L | 1.82 (0.78) | 2.47 (1.06) | 1.39 (0.48) | 2.61 (1.06) |
| Mercury, µg/L | 2.29 (1.71) | 3.94 (1.72) | 3.06 (2.42) | 3.71 (1.33) |
| Arsenic, µg/L | 6.89 (3.11) | 8.21 (2.94) | 7.29 (4.75) | 8.36 (3.86) |
| Copper, µg/L | 955.3 (116.0) | 994.7 (135.8) | 990 (151.9) | 1037 (149.7) |
| Cadmium, µg/L | 0.99 (0.38) | 1.03 (0.50) | 0.94 (0.43) | 0.96 (0.50) |
| Serum Iron, µg/dL | 66.1 (37.2) | 64.6 (32.8) | 74.7 (31.5) | 66.0 (30.4) |
| Hemoglobin, g/dL | 12.6 (0.89) | 12.4 (1.00) | 12.6 (0.85) | 12.6 (0.96) |
| Hematocrit, % | 38.8 (2.32) | 37.0 (2.42) | 38.6 (2.08) | 37.3 (2.34) |
Regulated limits and actual levels of heavy metals in the study product-FAD: lead<20 ppm, 0.45 ppm; arsenic<5 ppm, 0.14 ppm; cadmium<0.5 ppm, 0.01 ppm; mercury<0.5 ppm, 0.02 ppm.